William Hait - 03 Jan 2022 Form 3/A - Amendment Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Officer
Signature
Raavi Deol, as attorney-in-fact for William Hait
Issuer symbol
JNJ
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
3/A - Amendment
Filing time
18 Feb 2022, 12:59:15 UTC
Date Of Original Report
13 Jan 2022
Next filing
18 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JNJ Common Stock 71,609 03 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JNJ Employee Stock Options (Right to Buy) 03 Jan 2022 Common Stock 37,289 $129.51 Direct F2
holding JNJ Employee Stock Options (Right to Buy) 03 Jan 2022 Common Stock 33,593 $164.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Amended and Restated Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on January 13, 2022, which inadvertently included 151,549 shares not owned by the reporting person. This Form 3/A is deemed to update the number of securities reported as beneficially owned in the Form 4 filed on January 13, 2022.
F2 Vested and exercisable on the third anniversary of the date of the grant.

Remarks:

haitpoa1.txt Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer